The triple-combination therapy Trikafta significantly improved lung function and life quality in a global Phase 3 trial that enrolled…
Articles by Marisa Wexler, MS
Health Canada has extended the use of Kalydeco (ivacaftor) to treat babies, starting at 4 months old, who have cystic…
The Calgary and Southern Alberta Chapter of Cystic Fibrosis Canada has announced that this year’s 65 Roses Ladies Golf…
Voting is open for the 2021 Thriving Undergraduate and Thriving Graduate Scholarship, a program run by AbbVie that awards…
The World Health Organization (WHO) proposed a compound name to better identify MS1819, an investigational therapy for exocrine pancreatic insufficiency in…
Combining investigational therapy MS1819 with standard pancreatic enzyme replacement therapy (PERT) can improve fat absorption in people with cystic fibrosis…
People with cystic fibrosis (CF) who use opioids to manage pain commonly report being satisfied with the treatment, but…
Among people with cystic fibrosis (CF), antibiotic-resistant Staphylococcus aureus is sometimes transmitted among relatives, but rarely in healthcare settings, an…
A novel compound that may hold promise for treating the roughly 11% of cases of cystic fibrosis (CF) that…
Eloxx Pharmaceuticals announced it expects to share data later this year from the first four treatment groups of a Phase…